Fertility treatment in women with polycystic ovary syndrome: A decision analysis of different oral ovulation induction agents

Emily S. Jungheim, Anthony O. Odibo

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Abstract

Objective: To compare different oral ovulation induction agents in treating infertile women with polycystic ovary syndrome (PCOS). Design: Decision-analytic model comparing three treatment strategies using probability estimates derived from literature review and sensitivity analyses performed on the baseline assumptions. Setting: Outpatient reproductive medicine and gynecology practices. Patient(s): Infertile women with PCOS. Intervention(s): Metformin, clomiphene citrate, or metformin with clomiphene citrate. Main Outcome Measure(s): Live birth. Result(s): Within the baseline assumptions, combination therapy with metformin and clomiphene citrate was the preferred therapy for achieving live birth in women with PCOS. Sensitivity analysis revealed the model to be robust over a wide range of probabilities. Conclusion(s): Combination therapy with metformin and clomiphene citrate should be considered as first-line treatment for infertile women with PCOS.

Original languageEnglish
Pages (from-to)2659-2664
Number of pages6
JournalFertility and Sterility
Volume94
Issue number7
DOIs
StatePublished - Dec 2010

Keywords

  • Polycystic ovary syndrome
  • anovulation
  • clomiphene citrate
  • metformin

Fingerprint

Dive into the research topics of 'Fertility treatment in women with polycystic ovary syndrome: A decision analysis of different oral ovulation induction agents'. Together they form a unique fingerprint.

Cite this